drugset / Trial / NCT00127166
Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to determine the effect of four weeks of treatment with two investigational drugs (oral versus inhaled administration) plus an inhaled medication in the treatment of airway constriction brought on by exercise in participants with asthma.
Timeline
- Start
- 2005-12
- Primary completion
- 2008-11
- Completion
- 2008-11
Outcome
Met primary endpoint
paper Montelukast, compared with salmeterol, significantly reduced the mean maximum percentage decrease in FEV1 (10.6% vs 13.8%; P = .009) PMID 20568384 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Montelukast | Other / unclassified | 5 mg | Oral |
| Subject | Salmeterol | Other / unclassified | 50 ug | Inhaled |
| Background | Fluticasone | Other / unclassified | 100 ug | Inhaled |